• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

立体定向分割放射治疗能否成为早期非小细胞肺癌的标准治疗方法?

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

作者信息

Nguyen Nam P, Garland Linda, Welsh James, Hamilton Russ, Cohen Deirdre, Vinh-Hung Vincent

机构信息

Department of Radiation Oncology, University of Arizona, 1501 N. Campbell Avenue, Tucson, AZ, USA.

出版信息

Cancer Treat Rev. 2008 Dec;34(8):719-27. doi: 10.1016/j.ctrv.2008.06.001. Epub 2008 Jul 26.

DOI:10.1016/j.ctrv.2008.06.001
PMID:18657910
Abstract

Management of early stages non-small cell lung carcinoma has traditionally been surgery with radiation selected for medically inoperable patients. Recent emergence of stereotactic body radiation therapy allows for delivery of high radiation dose to the tumor while sparing normal lungs. This reviews compares loco-regional control, survival and complications rates between these two treatment modalities. Literature search identifies studies with stereotactic body radiation therapy and surgery for early stages non-small cell lung cancer. Effectiveness and toxicity of these two modalities was assessed. Stereotactic body radiation therapy is associated with minimal morbidity and provides comparable local control and survival in patients with multiple co-morbidities factors. Stereotactic body radiation therapy may become standard of care for operable early stages non-small cell lung cancer.

摘要

早期非小细胞肺癌的治疗传统上是手术,对于医学上无法手术的患者则选择放疗。立体定向体部放疗的出现使得在保护正常肺组织的同时能够向肿瘤输送高剂量辐射。本综述比较了这两种治疗方式在局部区域控制、生存率和并发症发生率方面的差异。文献检索确定了有关早期非小细胞肺癌立体定向体部放疗和手术的研究。评估了这两种方式的有效性和毒性。立体定向体部放疗的发病率极低,在有多种合并症因素的患者中能提供相当的局部控制和生存率。立体定向体部放疗可能会成为可手术的早期非小细胞肺癌的标准治疗方法。

相似文献

1
Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.立体定向分割放射治疗能否成为早期非小细胞肺癌的标准治疗方法?
Cancer Treat Rev. 2008 Dec;34(8):719-27. doi: 10.1016/j.ctrv.2008.06.001. Epub 2008 Jul 26.
2
Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).肿瘤大小很关键:立体定向体部放疗(SBRT)治疗 T1 和 T2 期周围型非小细胞肺癌的疗效比较。
J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9. doi: 10.1016/j.jtcvs.2010.01.046. Epub 2010 May 15.
3
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.立体定向体部放射治疗对无法手术的Ⅰ/Ⅱ期非小细胞肺癌患者的临床疗效显著。
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):117-25. doi: 10.1016/j.ijrobp.2006.04.013. Epub 2006 Jun 9.
4
Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.电视辅助胸腔镜手术及肺叶切除术、肺段切除术、射频消融术和立体定向放射外科手术:早期非小细胞肺癌治疗的进展与争议
Curr Opin Pulm Med. 2007 Jul;13(4):267-70. doi: 10.1097/MCP.0b013e3281c61a85.
5
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.高危患者 I 期肺癌的手术干预与立体定向体部放疗比较:决策分析。
J Thorac Cardiovasc Surg. 2012 Feb;143(2):428-36. doi: 10.1016/j.jtcvs.2011.10.078. Epub 2011 Dec 9.
6
Stereotactic body radiation therapy for stage I non-small cell lung cancer.立体定向体部放射治疗用于 I 期非小细胞肺癌。
Thorac Surg Clin. 2007 May;17(2):251-9. doi: 10.1016/j.thorsurg.2007.03.011.
7
Stereotactic body radiation therapy for lung cancer: achievements and perspectives.立体定向体部放疗治疗肺癌:成就与展望。
Jpn J Clin Oncol. 2010 Sep;40(9):846-54. doi: 10.1093/jjco/hyq134. Epub 2010 Jul 29.
8
Stereotactic radiosurgery for early stage non-small cell lung cancer: rationale, patient selection, results, and complications.早期非小细胞肺癌的立体定向放射外科治疗:原理、患者选择、结果及并发症
Semin Thorac Cardiovasc Surg. 2008 Winter;20(4):290-7. doi: 10.1053/j.semtcvs.2008.12.001.
9
Surgical treatment of stage I non-small cell lung carcinoma.I期非小细胞肺癌的外科治疗
Ann Thorac Cardiovasc Surg. 2003 Oct;9(5):283-9.
10
Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.立体定向体部放疗与手术治疗可手术的 I 期非小细胞肺癌:基于马尔可夫模型的决策分析。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):964-73. doi: 10.1016/j.ijrobp.2010.06.040. Epub 2010 Oct 6.

引用本文的文献

1
Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance.基于实时MRI引导的肺部肿瘤自适应低分割立体定向体部放疗
Front Oncol. 2023 Jan 27;13:1061854. doi: 10.3389/fonc.2023.1061854. eCollection 2023.
2
The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy-rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial.新辅助立体定向体部放射治疗(SBRT)联合肺转移瘤切除术的组织学效应——SBRT后肺转移瘤切除术(PSPM)试验的理论依据和方案设计
Transl Cancer Res. 2022 Apr;11(4):918-927. doi: 10.21037/tcr-22-232.
3
Toxicity and efficacy of stereotactic body radiotherapy for ultra-central lung tumours: a single institution real life experience.
立体定向体部放疗治疗超中心型肺部肿瘤的毒性和疗效:单机构真实世界经验。
Br J Radiol. 2022 Jan 1;95(1129):20210533. doi: 10.1259/bjr.20210533. Epub 2021 Nov 26.
4
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [F]FDG PET and CT perfusion: a prospective exploratory clinical study.使用定量动态 [F]FDG PET 和 CT 灌注预测肺癌立体定向消融放疗后的病理完全缓解 (pCR):一项前瞻性探索性临床研究。
Radiat Oncol. 2021 Jan 13;16(1):11. doi: 10.1186/s13014-021-01747-z.
5
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.早期非小细胞肺癌和间质性肺病精准放疗评估(ASPIRE-ILD):一项 II 期试验的研究方案。
BMC Cancer. 2019 Dec 11;19(1):1206. doi: 10.1186/s12885-019-6392-8.
6
Pathologic response after modern radiotherapy for non-small cell lung cancer.非小细胞肺癌现代放疗后的病理反应
Transl Lung Cancer Res. 2019 Sep;8(Suppl 2):S124-S134. doi: 10.21037/tlcr.2019.09.05.
7
Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time.立体定向消融放疗用于可手术的Ⅰ期非小细胞肺癌:尚未准备好进入黄金时代。
Ann Transl Med. 2019 Sep;7(Suppl 6):S234. doi: 10.21037/atm.2019.08.40.
8
SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer.SUVmax 预测Ⅰ期非小细胞肺癌立体定向消融放疗后的疾病进展。
Cancer Res Treat. 2020 Jan;52(1):85-97. doi: 10.4143/crt.2019.007. Epub 2019 May 17.
9
Challenges Facing Radiation Oncologists in The Management of Older Cancer Patients: Consensus of The International Geriatric Radiotherapy Group.老年癌症患者放疗管理中放射肿瘤学家面临的挑战:国际老年放疗小组共识
Cancers (Basel). 2019 Mar 16;11(3):371. doi: 10.3390/cancers11030371.
10
Stereotactic body radiotherapy for stage I non-small cell lung cancer.I期非小细胞肺癌的立体定向体部放射治疗
J Radiosurg SBRT. 2011;1(1):63-69.